IN PARTNERSHIP
Seven steps to facilitate the adoption of hybrid decentralised trial technology
Nicole Latimer, CEO of Medrio, reveals how the company’s flexible suite of eClinical technologies and services can simplify today’s hybrid decentralised and site-based clinical trials.
R
educing friction for sites introducing ePRO technology starts with setting up an ecosystem to support that change.
Hybrid decentralised trial technology has the potential to transform1
the way we think about
clinical trials and the data those efforts produce – but when is it the right time to introduce this newer technology? It isn’t a question of what the tech can do but whether the ecosystem can support that change. Sponsors can ease the way for clinical trials to
technology by taking the following steps.
1. Start with “why”. At Medrio, we see ePRO technology leveraged across a variety of patient data collection scenarios. Common uses for ePRO can include: • Automatic reminders for complex dosing diaries
• Quality of life or functional status surveys
• Real-time visibility into the participant experience
Because ePRO can be used differently in each
study, it is important for sponsors to ensure sites understand the relevance of the information collected through ePRO so sites can leverage that information to instruct participants.
2. Drive technology launch to participants Sites are craving training and materials to assist with introducing ePRO to participants. Because ePRO is versatile, sites often cannot recycle training materials from previous studies even when using the same system – not to mention those using various ePRO systems across their studies as dictated by different sponsors and
3. Offer adequate training for sites According to the 2021 Site Landscape survey published by the SCRS2
, sites need greater
assistance in adopting new technologies. When asked, sites suggested the following: 1. Technology adoption guidance 2. Participant technical support 3. Participant training materials and resources
4. Integration and consistency of tech 5. Assistance with regulatory requirements 6. Site personnel training 7. Site technical support
These translate into additional training being required when hybrid and decentralised trial technologies are incorporated – on average, an increase to 17.5 hours per month2
. When 29%
margins, their frustration with and reluctance to adopt hybrid technologies is understandable2
.
4. Select an intuitive ePRO system Not all ePRO systems are equal when it comes to usability. Many require extra effort for sites and participants. Systems with dedicated hardware require distribution and replacement costs, and this increases training time. App- based ePRO systems require sites to ensure participants can access an app store, download the application, register, and download updates. In a cloud-based ePRO system, participants
receive a text or email on their own devices that contains a link to the ePRO surveys. Participants
Outsourcing in Clinical Trials Handbook | 33
CROs. Consistent technology helps sponsors provide participants with regularity, thereby reducing the burden for both participants who need to learn and staff who need to train them.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
